Meclinertant

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameMeclinertant
Drug Alias NameMeclinertantum美克纳坦美兰纳坦SR-48692
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotensin antagonists
TargetsNeurotensin
Therapy Area/IndicationsSmall Cell Lung CarcinomaLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPolandNetherlands +[14] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaLung Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia